Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Medtronic spinout Inspire Medical closes $38m Series F
Inspire Medical Systems, which spun out from Medtronic in 2007, said yesterday it closed a $37.5 million Series F financing round, as well as announcing the appointment of Marilyn Nelson to the board of directors.
Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep. Read more
4. FDA joins pact for cybersecurity in medical devices
The FDA’s Center for Devices and Radiological Health inked a pact with the National Health Information Sharing and Analysis Center and the Medical Device Innovation, Safety and Security Consortium, looking to improve data sharing and cybersecurity in the industry.
The groups are looking to collaborate on 4 points, according to a press release from the National Health Information Sharing and Analysis Center. Read more
3. Smith & Nephew recalls Modular SMF, Modular Redapt hip implants
Smith & Nephew this week recalled its Modular SMF and Modular Redapt hip implants “due to a higher than anticipated complaint and adverse event trend” with the modular necks used in the devices.
“Based on an analysis of available data sets, Smith & Nephew considers that patients implanted with the modular neck hip prostheses may be at greater risk of revision surgery than with comparable monolithic products,” the company wrote in a Nov. 15 “Dear Doctor” letter. “For this reason, on a precautionary basis Smith & Nephew is issuing a voluntary field safety corrective action for the modular neck hip prostheses.” Read more
2. Appeals court upholds $15m Medtronic loss to bone cement acquisition Pabban Development
Medtronic is still on the hook to pay $15.4 million to bone cement maker Pabban Development for breaking the terms their 2008 acquisition deal, a federal appeals court ruled yesterday.
Irvine, Calif.-based Pabban, which developed a bone cement system for spinal surgeries called Natrix, claimed the technology had key improvements over other bone cements at the time, according to court documents. That aroused Medtronic’s interest after the Federal Trade Commission ruled that its July 2007 acquisition of Kyphon could only go through if Kyphon sold off its bone cement delivery system, according to the documents (Johnson DePuy subsidiary acquired the Kyphon system for roughly $100 million in 2008). Read more
1. Alere agrees to cough up probe docs to Abbott
Alere shares rose yesterday after it agreed to give documents to Abbott, which is hoping to rescind its $6 billion offer to acquire the diagnostics company, covering probes into Alere’s dealings with 3rd-party distributors and foreign healthcare officials.
The companies have sued each other in a Delaware state court, with Abbott seeking to compel Alere to produce the documents and Alere seeking to force the deal to close. This week Alere agreed to cough up the documents; the companies revealed the settlement Nov. 15 in a hearing at the Delaware Chancery Court, according to news reports. Read more
The post MassDevice.com +5 | The top 5 medtech stories for November 17, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2gkY31V
Cap comentari:
Publica un comentari a l'entrada